Bioanalytical Services for Anti-Aging Drug Development

With the aging population increasingly seeking interventions to enhance longevity and quality of life, the demand for reliable bioanalytical services has never been higher. Bioanalysis plays a vital role in the early development of anti-aging drugs. The data is essential for tailoring and optimizing formulations to address the unique pharmacological needs of the elderly, who may exhibit altered drug responses due to aging-related physiological changes. At CD BioSciences, our comprehensive bioanalytical services are customized to support the development of safe and effective anti-aging therapeutics through advanced methodologies and technologies.

What Types of Anti-Aging Drugs Do We Analyze?

• Bioanalytical services for small molecule drugs. Small molecules are a cornerstone of anti-aging drug development, often designed to interact with specific biological targets. We provide highly sensitive assays for quantifying small molecules in biological matrices, using techniques like Liquid chromatography-tandem mass spectrometry (LC-MS/MS) and gas chromatography (GC). Additionally, we help clients identify and quantify drug metabolites to uncover the metabolic pathways and potential side effects.
• Bioanalytical services for biologics. We assist in performing bioanalytical services of biologics with anti-aging effects, including monoclonal antibodies and therapeutic proteins. We utilize enzyme-linked immunosorbent assays (ELISA) and other immunoassay techniques to measure the concentration of biologics in biological samples. Our services also include characterization of biologics, focusing on post-translational modifications, aggregation states, and isoform detection, which are critical for understanding their anti-aging effects and therapeutic potential.

Our Bioanalytical Services for Anti-Aging Drug Development

Bioanalytical mass spectrometry services

Utilizing LC-MS/MS and liquid chromatography-high resolution mass spectrometry (LC-MS, HRMS) platforms, we provide advanced bioanalytical services for the quantification of anti-aging drugs and their metabolites. Our team of experienced scientists emphasizes key factors such as assay sensitivity, temporal stability, sample matrix complexity, throughput optimization, and workflow automation to support high-volume sample analysis with consistent accuracy and efficiency.

Ligand binding assays

Ligand binding assays are essential for assessing the interaction between anti-aging drugs and their biological targets. At CD BioSciences, we offer ligand-binding assays to support all stages of anti-aging drug development. We provide competitive binding assays to determine drug concentrations and binding efficiencies, as well as specialized assays to assess target occupancy. Our experts employ surface plasmon resonance (SPR) technology for real-time monitoring of ligand-receptor interactions, providing kinetic parameters essential for drug development.

Our Platforms for Bioanalytical Services in Anti-Aging Drug Development

CD BioSciences utilizes a range of advanced analytical platforms to ensure the accuracy, sensitivity, and reliability of our bioanalytical services. By integrating technologies into our workflows, we provide robust support for clients to accelerate and optimize their anti-aging drug development projects.

• High-resolution MS, LC-MS, LC-HRMS
• Liquid chromatography (HPLC, UHPLC) with UV, fluorescence, evaporative light scattering detection (ELSD), and radiolabelled detection
• Gas chromatography (GC) with MS, flame ionization detector (FID), and electron capture (EC) detection

With our expertise in mass spectrometry and ligand binding assays, CD BioSciences offers specialized bioanalytical services to facilitate the advancement of anti-aging therapeutics. If you are interested in our services, please feel free to contact us or make an online inquiry.